NEW YORK-- Shares of kidney dialysis provider DaVita HealthCare Partners Inc. rose Tuesday after Medicare said it does not expect to cut payments for the popular Medicare Advantage program in 2014..
Humana Inc said on Tuesday that the government's move is an improvement over earlier proposals, but it still faces challenges in certain parts of the country.
Health insurance stocks like Humana broke out sharply on Monday after the CMS increased the Medicare Advantage rate. The FMHR traders and Steve Grasso discuss how to play these stocks. Also, whether to get cautious on news the Dow has set a new intraday high in 12 of the past 20 trading sessions, with Jason Pride, Glenmede.
April 2- Humana Inc said on Tuesday that the government's increase in its payment rate for Medicare Advantage in 2014 is an improvement over a proposed reduction but said that "meaningful challenges" in certain geographical areas are ahead.
Shares of several health insurers climbed in premarket trading Tuesday, a day after the federal government released final Medicare Advantage rate data for next year that points to less severe funding cuts than investors had originally feared.
Health insurance stocks were mixed Monday as investors and analysts await final word from the federal government on Medicare Advantage rates for 2014..
March 27 Reuters)- Planned cuts in U.S. government payments for private Medicare Advantage insurance may not be as severe as first proposed, a prospect that could boost the shares of insurers such as Humana Inc and UnitedHealth Group Inc.
The study by the Society of Actuaries comes as lawmakers are still trying to decide whether they will offer health coverage to an expanded Medicaid population and how they will draft state insurance regulations to conform with the federal health law.
Hospitals will face reimbursement challenges that include pressure from government programs like Medicare Advantage, but the business they gain from the health care overhaul's coverage expansion still supports strong 2014 earnings growth, according to BMO Capital Markets analyst Jennifer Lynch.